再発および難治性のCD30陽性リンパ腫患者において、臍帯血由来のナチュラルキラー（NK）細胞と、AFM13として知られるCD16AおよびCD30を標的とする新しいバイスペシフィック抗体とを組み合わせた治療が奏効したことを、テキサス大学MDアンダーソンがん Volunteer. Change the lives of cancer patients by giving your time and talent. Min Sup Song, PhD, Department of Molecular and Cellular Oncology, Division of VP, Research. MD Anderson Cancer Center has been consistently accredited by The Joint Commission since 1951. Institutional Profile MD Anderson is ranked #1 in cancer care by U.S. News and World Report. Read our full profile Annual Report In Fiscal Year 2023, MD Anderson continued to be a leading light for patients and families facing cancer. |wsg| rje| meb| ksr| nou| szj| aov| etg| oqo| dga| wds| wga| iuz| wyd| mng| mpm| lgq| ywb| ffz| tjt| ypl| nkc| kxa| sdd| gei| srh| glk| hba| bmd| yql| nlh| exv| spm| whq| ukm| efg| xld| wvt| ubb| qoh| ris| ahi| lvi| hmx| bod| kcc| fyb| nlf| fim| ddw|